Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Mallinckrodt
Medtronic
Colorcon
Express Scripts

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Litigation Details for Snipe v. Gilead Sciences, Inc. (N.D. Cal. 2019)

See Plans and Pricing

« Back to Dashboard

Snipe v. Gilead Sciences, Inc. (N.D. Cal. 2019)

Docket   Start Trial Date Filed 2019-05-20
Court District Court, N.D. California Date Terminated
Cause 15:1 Antitrust Litigation Assigned To Beth Labson Freeman
Jury Demand Plaintiff Referred To Virginia K. Demarchi
Parties AKROS PHARMA INC.; BRISTOL-MYERS SQUIBB COMPANY; E. R. SQUIBB & SONS, L.L.C.; GABRIEL MOLINA; GILEAD HOLDINGS, LLC; GILEAD SCIENCES IRELAND UC; GILEAD SCIENCES, INC.; GILEAD SCIENCES, LLC; JANSSEN R&D IRELAND; JAPAN TOBACCO INTERNATIONAL U.S.A., INC.; JAPAN TOBACCO, INC.; JOHN CARROLL; JOHN DOE; JOHNSON & JOHNSON, INC.; JOSH MCDONALD; MICHAEL SNIPE; TROY VAZQUEZ-CAIN
Patents 5,922,695; 5,935,946; 5,977,089; 6,043,230; 7,390,791; 7,803,788; 8,754,065; 9,296,769
Attorneys Kevin Francis Ruf; Linda Phyllis Nussbaum; Lionel Z. Glancy
Firms Glancy Prongay & Murray LLP; Nussbaum Law Group, P.C.
Link to Docket External link to docket
Small Molecule Drugs cited in Snipe v. Gilead Sciences, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Snipe v. Gilead Sciences, Inc. (N.D. Cal. 2019)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 Complaint Gilead’s basic patents claiming TDF and certain methods of using it—patents 22 5,922,695; 5,935,946; …listed patent(s) and/or the patent is invalid and 18 unenforceable. Simply by listing the patents in the…ANDA applicant for patent 23 infringement. If the brand manufacturer brings a patent infringement action…legitimate patent protection or ferret out invalid, unenforceable, or 24 narrow drug patents. 25 …even after the 21 patents on them expired. 22 86. Gilead’s patents on TDF, FTC, and TDF External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Boehringer Ingelheim
Moodys
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.